However, the clinical efficacy and safety of immunosuppressants (including TCZ, sarilumab and anakinra) in COVID-19 patients are not yet known. These treatments may predispose patients to infection. The aim of this study was to find any connection between the use ...
of co-infections (as well as superinfections) in patients with COVID infection on hospital admission for more targeted initial antibiotic use, and to this end, it has been suggested that procalcitonin, in particular, may be a useful biomarker [27]. In the very early study from Wuhan, most ...
and to this end, it has been suggested that procalcitonin, in particular, may be a useful biomarker [27]. In the very early study from Wuhan, most patients with COVID infection had normal procalcitonin levels on admission, but four patients...
age ≥ 18 years, (2) cared for by the critical care team in an ICU or other area of the hospital on the above-mentioned date, (3) had PCR (or equivalent technique) confirmed Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2) infection and (4) had a diagnosis of COVID-...
This model recommends a diagnostic test with diagnostic sensitivity [≥] 96% and at least 92% lower bound limit of the 95% CI or [≤] 4% margin of error for a highly infectious diseases like COVID-19 to curb the secondary transmission of the infection due to false negative cases. ...
COVID-19 patients with fewcomorbidities and without severe multisystem organ failure. 8Although it has been utilized worldwide for patients withCOVID-19, no data on secondary infections in these patientsare available. 9 In this study, we retrospectively compared secon-dary infection rates on ECMO ...
Because of national shortages in PCR testing, only 34.1% (14 of 41) of nonhospitalized cases of COVID-19 were molecularly confirmed in this study. It is possible that these individuals may have suffered a clinically indistinguishable, non–SARS-CoV-2 infection. However, the overall inpatient mo...
COVID-19 primarily presents as a respiratory tract infection with symptoms varying from mild flu-like illness to acute respiratory distress syndrome (ARDS) [2, 3]. Viral-related respiratory infections belonging to the same family of coronaviruses such as SARS-CoV and Middle East respiratory ...
Secondary hyperhidrosis is a multifactorial condition that poses unique diagnostic and management challenges. Distinguishing secondary from primary hyperhi
These findings suggest that higher pre-infection HONOS scores may be associated with subsequent death from COVID-19, but that these items are largely explained by age and diagnosis (of dementia). We are therefore cautious about whether HoNOS, on its own, can be used as a reliable predictor...